Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of KetoNaph Ophthalmic Solution in Healthy Volunteers and Pediatric Subjects
NCT01159015Phase 3Completed
- Sponsor
- Bausch + Lomb
- Start
- Jul 2010
- Primary completion
- Sep 2010
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ketotifen, naphazoline in allergic conjunctivitis (AC), sponsored by Bausch + Lomb. Started Jul 2010; status: completed.
02
Drugs
ketotifennaphazoline
03
Conditions
allergic conjunctivitis (AC)
Beyond the preview
Go deeper on NCT01159015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01159015.